MiMedx Group (MDXG) Tops Q2 EPS by 2c

MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $81.3 million versus the consensus estimate of $74.84 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Truist upgrades Biogen to Buy on Alzheimer's, pipeline optimism ahead of key data
• Nio gains after Goldman ups stock to Buy on strong growth, compelling valuation